These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 34057390)
21. Impact of adherence and weight loss on glycemic control in patients with type 2 diabetes: cohort analyses of integrated medical record, pharmacy claims, and patient-reported data. McAdam-Marx C; Bellows BK; Unni S; Wygant G; Mukherjee J; Ye X; Brixner DI J Manag Care Spec Pharm; 2014 Jul; 20(7):691-700. PubMed ID: 24967522 [TBL] [Abstract][Full Text] [Related]
22. Identifying adherent patients to newly initiated statins using previous adherence to chronic medications. Majd Z; Mohan A; Paranjpe R; Abughosh SM J Manag Care Spec Pharm; 2021 Feb; 27(2):186-197. PubMed ID: 33506725 [No Abstract] [Full Text] [Related]
23. A Payer Perspective of the Costs of Urinary Tract and Skin and Soft Tissue Infections in Adults with Diabetes and the Relationship to Oral Antidiabetic Medication Nonadherence. Davis-Ajami ML; Pakyz A; Wu J; Baernholdt M J Manag Care Spec Pharm; 2019 Dec; 25(12):1409-1419. PubMed ID: 31436479 [TBL] [Abstract][Full Text] [Related]
24. One-year adherence to oral antihyperglycemic medication and risk prediction of patient outcomes for adults with diabetes mellitus: An observational study. Huber CA; Rapold R; Brüngger B; Reich O; Rosemann T Medicine (Baltimore); 2016 Jun; 95(26):e3994. PubMed ID: 27368004 [TBL] [Abstract][Full Text] [Related]
25. Association Between Supplemental Nutrition Assistance Program Participation and Cost-Related Medication Nonadherence Among Older Adults With Diabetes. Pooler JA; Srinivasan M JAMA Intern Med; 2019 Jan; 179(1):63-70. PubMed ID: 30453334 [TBL] [Abstract][Full Text] [Related]
26. The effects of oral anticancer parity laws on out-of-pocket spending and adherence among commercially insured patients with chronic myeloid leukemia. Spargo A; Yost C; Squires P; Raju A; Schroader B; Brown JD J Manag Care Spec Pharm; 2021 May; 27(5):554-564. PubMed ID: 33908275 [No Abstract] [Full Text] [Related]
27. Comparison of oral anticoagulation use and adherence among Medicare beneficiaries enrolled in stand-alone prescription drug plans vs Medicare Advantage prescription drug plans. Newman TV; Gabriel N; Liang Q; Drake C; El Khoudary SR; Good CB; Gellad WF; Hernandez I J Manag Care Spec Pharm; 2022 Feb; 28(2):266-274. PubMed ID: 35098746 [No Abstract] [Full Text] [Related]
28. Impact of a text messaging pilot program on patient medication adherence. Foreman KF; Stockl KM; Le LB; Fisk E; Shah SM; Lew HC; Solow BK; Curtis BS Clin Ther; 2012 May; 34(5):1084-91. PubMed ID: 22554973 [TBL] [Abstract][Full Text] [Related]
29. Assessing the association between medication adherence, as defined in quality measures, and disease-state control, health care utilization, and costs in a retrospective database analysis of Medicare supplemental beneficiaries using statin medications. Axon DR; Vaffis S; Chinthammit C; Lott BE; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ J Manag Care Spec Pharm; 2020 Dec; 26(12):1529-1537. PubMed ID: 33251989 [No Abstract] [Full Text] [Related]
30. The Impact of Patient-Centered Medical Homes on Quality of Care and Medication Adherence in Patients with Diabetes Mellitus. An J J Manag Care Spec Pharm; 2016 Nov; 22(11):1272-1284. PubMed ID: 27783547 [TBL] [Abstract][Full Text] [Related]
31. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid. Oladapo AO; Barner JC; Rascati KL; Strassels SA Clin Ther; 2012 Mar; 34(3):605-13. PubMed ID: 22386828 [TBL] [Abstract][Full Text] [Related]
32. Adherence to oral antidiabetic agents with pioglitazone and metformin: comparison of fixed-dose combination therapy with monotherapy and loose-dose combination therapy. Barner JC Clin Ther; 2011 Sep; 33(9):1281-8. PubMed ID: 21840054 [TBL] [Abstract][Full Text] [Related]
33. Retrospective Study on the Impact of Adherence in Achieving Glycemic Goals in Type 2 Diabetes Mellitus Patients Receiving Canagliflozin. Buysman EK; Anderson A; Bacchus S; Ingham M Adv Ther; 2017 Apr; 34(4):937-953. PubMed ID: 28251556 [TBL] [Abstract][Full Text] [Related]
34. Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries. Sacks NC; Burgess JF; Cabral HJ; Pizer SD; McDonnell ME J Gen Intern Med; 2013 Jul; 28(7):876-85. PubMed ID: 23404199 [TBL] [Abstract][Full Text] [Related]
35. Tyrosine Kinase Inhibitors and the Relationship With Adherence, Costs, and Health Care Utilization in Commercially Insured Patients With Newly Diagnosed Chronic Myeloid Leukemia: A Retrospective Claims-Based Study. Phuar HL; Begley CE; Chan W; Krause TM Am J Clin Oncol; 2020 Jul; 43(7):517-525. PubMed ID: 32304434 [TBL] [Abstract][Full Text] [Related]
36. Impact of pharmacy services on initial clinical outcomes and medication adherence among veterans with uncontrolled diabetes. Gatwood JD; Chisholm-Burns M; Davis R; Thomas F; Potukuchi P; Hung A; Shawn McFarland M; Kovesdy CP BMC Health Serv Res; 2018 Nov; 18(1):855. PubMed ID: 30428877 [TBL] [Abstract][Full Text] [Related]
37. Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients. Laliberté F; Nelson WW; Lefebvre P; Schein JR; Rondeau-Leclaire J; Duh MS Adv Ther; 2012 Aug; 29(8):675-90. PubMed ID: 22898791 [TBL] [Abstract][Full Text] [Related]
38. Venue of receiving diabetes self-management education and training and its impact on oral diabetic medication adherence. Wu J; Davis-Ajami ML; Noxon V; Lu ZK Prim Care Diabetes; 2017 Apr; 11(2):162-170. PubMed ID: 27840086 [TBL] [Abstract][Full Text] [Related]
39. Atypical antipsychotic adherence is associated with lower inpatient utilization and cost in bipolar I disorder. Broder MS; Greene M; Chang E; Hartry A; Yan T; Yermilov I J Med Econ; 2019 Jan; 22(1):63-70. PubMed ID: 30376745 [TBL] [Abstract][Full Text] [Related]
40. Health care resource utilization and costs associated with nonadherence and nonpersistence to antidepressants in major depressive disorder. Ta JT; Sullivan SD; Tung A; Oliveri D; Gillard P; Devine B J Manag Care Spec Pharm; 2021 Feb; 27(2):223-239. PubMed ID: 33506730 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]